Total Funding
32
5
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
415413
Zebra Biologics develops bio superior agonist and antagonist antibody therapeutics for many diseases.
Past Role: Second Genome, Sr VP Research & Development
Paul Greengard: Co-Founder
About the Company
Zebra Biologics, Inc., a biotechnology company, discovers and develops biosuperior antibody therapeutics and complex drug targets.
The company was founded in 2013 and is based in Concord, Massachusetts.
